Status:
UNKNOWN
Women in Cardiac Rehabilitation: Optimizing the Training Response
Lead Sponsor:
University of Vermont
Conditions:
Exercise Training
Coronary Artery Disease
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) is highly prevalent in women resulting in 398,086 deaths annually. Even as women participate in traditional CR programs, data specificity and subsequent research have yet ...
Detailed Description
Cardiovascular disease (CVD) is the foremost leading cause of death in women.1 More than 1 in 3 female adults are affected by CVD.2 Though the prevalence of CVD in women remains high, there is a relat...
Eligibility Criteria
Inclusion
- Heart disease, eligible for cardiac rehabilitation -
Exclusion
- Peak VO2 \< 12 ml/kg/min
- \-
Key Trial Info
Start Date :
August 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03438968
Start Date
August 24 2017
End Date
April 30 2019
Last Update
February 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vermont College of Medicine
Burlington, Vermont, United States, 05401